As a result, CRP levels were substantially higher in the HS patient group (2571.0 ± 509.3 ng/mL) compared to the control group (620.7 ± 230.2 ng/mL) (Figure 4A; p = 0.0080). The gene discussed is CRP; the disease is histiocytic sarcoma.